{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:38:24Z","timestamp":1771501104925,"version":"3.50.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/wnf.0000000000000085","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T01:37:58Z","timestamp":1431481078000},"page":"104-108","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacological Agents in Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1097","volume":"38","author":[{"given":"R\u00e9za","family":"Behrouz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Sadat-Hosseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.STR.28.3.660","article-title":"Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.","volume":"28","author":"Hop","year":"1997","journal-title":"Stroke"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasma controlled trial of nimodipine in patients with subarachnoid hemorrhage.","volume":"308","author":"Allen","year":"1983","journal-title":"N Engl J Med"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.wneu.2011.09.030","article-title":"A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.","volume":"78","author":"Soppi","year":"2012","journal-title":"World Neurosurg"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00228-007-0267-7","article-title":"Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhagea pilot study.","volume":"63","author":"Soppi","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart AssociationAmerican Stroke Association.","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3171\/jns.1993.78.4.0548","article-title":"A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study.","volume":"78","author":"Haley","year":"1993","journal-title":"J Neurosurg"},{"issue":"2","key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12028-007-9017-z","article-title":"Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage.","volume":"8","author":"Goodson","year":"2008","journal-title":"Neurocrit Care"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12028-009-9307-8","article-title":"The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage.","volume":"12","author":"Webb","year":"2010","journal-title":"Neurocrit Care"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12028-011-9659-8","article-title":"Intraventricular nicardipine for aneurysmal subarachnoid hemorrhage related vasospasm: assessment of 90 days outcome.","volume":"16","author":"Lu","year":"2012","journal-title":"Neurocrit Care"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/02688697.2010.548878","article-title":"Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage.","volume":"25","author":"Barth","year":"2011","journal-title":"Br J Neurosurg"},{"key":"R12-4-20210203","first-page":"77","article-title":"A simplified method for administration of intra-arterial nicardipine for vasospasm with cervical catheter infusion.","volume":"71","author":"Pandey","year":"2012","journal-title":"Neurosurgery"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3171\/jns.1968.28.1.0021","article-title":"Antifibrinolytic therapy for intracranial aneurysms.","volume":"28","author":"Mullan","year":"1968","journal-title":"J Neurosurg"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.wneu.2012.05.010","article-title":"Treatment of ruptured middle cerebral aneurysms associated with intracerebral hematomas.","volume":"80","author":"Schuette","year":"2013","journal-title":"World Neurosurg"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage.","volume":"311","author":"Vermeulen","year":"1984","journal-title":"N Engl J Med"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial.","volume":"54","author":"Roos","year":"2000","journal-title":"Neurology"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1227\/NEU.0b013e3181ebaa36","article-title":"Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus.","volume":"67","author":"Harrigan","year":"2010","journal-title":"Neurosurgery"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.","volume":"97","author":"Hillman","year":"2002","journal-title":"J Neurosurg"},{"key":"R19-4-20210203","first-page":"CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.","volume":"8","author":"Baharoglu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1227\/01.NEU.0000043984.42487.0E","article-title":"Hypomagnesemia after aneurysmal subarachnoid hemorrhage.","volume":"52","author":"van den Bergh","year":"2003","journal-title":"Neurosurgery"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3171\/jns.2002.96.3.0510","article-title":"Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.","volume":"96","author":"Veyna","year":"2002","journal-title":"J Neurosurg"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00008506-200604000-00009","article-title":"Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study.","volume":"18","author":"Wong","year":"2006","journal-title":"J Neurosurg Anesthesiol"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/01.STR.0000160801.96998.57","article-title":"Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.","volume":"36","author":"van den Bergh","year":"2005","journal-title":"Stroke"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/STROKEAHA.109.571125","article-title":"Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.","volume":"41","author":"Wong","year":"2010","journal-title":"Stroke"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(12)60724-7","article-title":"Magnesium for aneurysmal subarachnoid haemorrhage(MASH-2): a randomized placebo-controlled trial.","volume":"380","author":"Dorhout Mees","year":"2012","journal-title":"Lancet"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12028-014-9964-0","article-title":"Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.","volume":"21","author":"Reddy","year":"2014","journal-title":"Neurocrit Care"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.30.9.1969","article-title":"Neuroprotective properties of statins in cerebral ischemia and stroke.","volume":"30","author":"Vaughan","year":"1999","journal-title":"Stroke"},{"key":"R28-4-20210203","first-page":"646","article-title":"Statins: a potential therapeutic addition to treatment for aneurysmal subarachnoid hemorrhage World N","volume":"73","author":"Sabri","year":"2010","journal-title":"eurosurg"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"; STASH Collaborators. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.","volume":"13","author":"Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/srep04573","article-title":"Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.","volume":"4","author":"Su","year":"2014","journal-title":"Sci Rep"},{"key":"R32-4-20210203","first-page":"11","article-title":"Aspirin and intracerebral hemorrhage: where are we now Neurol Clin P","volume":"5","author":"Behrouz","year":"2015","journal-title":"ract"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/01.STR.21.4.566","article-title":"Platelet thromboxane release after subarachnoid hemorrhage and surgery.","volume":"21","author":"Juvela","year":"1990","journal-title":"Stroke"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.54.4.872","article-title":"Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage.","volume":"54","author":"Hop","year":"2000","journal-title":"Neurology"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/01.STR.0000236841.16055.0f","article-title":"Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study.","volume":"37","author":"van den Bergh","year":"2006","journal-title":"Stroke"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/STROKEAHA.108.528802","article-title":"Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage.","volume":"40","author":"van den Bergh","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"R37-4-20210203","first-page":"CD006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/STROKEAHA.111.619411","article-title":"Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture.","volume":"42","author":"Hasan","year":"2011","journal-title":"Stroke"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population.","volume":"81","author":"Garcia-Rodriguez","year":"2013","journal-title":"Neurology"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/jcbfm.2012.84","article-title":"Biology of intracranial aneurysms: role of inflammation.","volume":"32","author":"Chalouhi","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3171\/2009.4.JNS081377","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage.","volume":"112","author":"Gomis","year":"2010","journal-title":"J Neurosurg"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.","volume":"39","author":"Macdonald","year":"2008","journal-title":"Stroke"},{"key":"R43-4-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol"},{"issue":"2","key":"R44-4-20210203","first-page":"CD006778","article-title":"Tirilazad for aneurysmal subarachnoid haemorrhage.","author":"Zhang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3171\/jns.1995.82.5.0786","article-title":"Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.","volume":"82","author":"Haley","year":"1995","journal-title":"J Neurosurg"},{"key":"R46-4-20210203","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3171\/jns.2003.99.6.0953","article-title":"No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.","volume":"99","author":"Siironen","year":"2003","journal-title":"J Neurosurg"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"e71405","DOI":"10.1371\/journal.pone.0071405","article-title":"Tonic-clonic activity at subarachnoid hemorrhage onset: impact on complications and outcome.","volume":"8","author":"De Marchis","year":"2013","journal-title":"PLoS One"},{"key":"R48-4-20210203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3171\/JNS-07\/08\/0253","article-title":"Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs.","volume":"107","author":"Rosengart","year":"2007","journal-title":"J Neurosurg"},{"key":"R49-4-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1586\/erc.10.189","article-title":"Cardiac manifestations of subarachnoid hemorrhage.","volume":"9","author":"Behrouz","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R50-4-20210203","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart AssociationAmerican Stroke Association.","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:10:12Z","timestamp":1620976212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201505000-00004"}},"subtitle":["Successes and Failures"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000085","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}